An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks.
Prog Neuropsychopharmacol Biol Psychiatry
; 9(5-6): 589-92, 1985.
Article
em En
| MEDLINE
| ID: mdl-3911285
ABSTRACT
Imipramine, phenelzine and alprazolam have each been shown to be efficacious in the treatment of panic disorder and in agoraphobia with panic attacks. Clonazepam, a 1,4 benzodiazepine derivative used mainly in neurology as an anti-epileptic, has specific pharmacodynamic and pharmacokinetic properties which would make it an advantageous antipanic agent. We report 8 cases of recurrent panic attacks which were successfully treated with clonazepam.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Ansiedade
/
Pânico
/
Benzodiazepinonas
/
Clonazepam
/
Medo
Limite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
1985
Tipo de documento:
Article